Indian billionaires buy foreign companies as growth slows at home
Summary
Indian companies are buying foreign businesses at a fast pace as growth slows in India. In 2025, they spent over $18 billion on overseas deals, including big purchases like Sun Pharmaceuticals acquiring Organon & Co for $11.75 billion.Key Facts
- Sun Pharmaceuticals paid $11.75 billion to buy Organon & Co, a New York-listed company, in 2025.
- Tata Motors acquired Italian vehicle maker Iveco for $4.4 billion.
- Indian IT company Coforge bought Silicon Valley AI firm Encora for $2.35 billion.
- The Bajaj Group bought a 23% stake in German insurance company Allianz SE.
- Indian firms spent over $18 billion on foreign acquisitions in 2025, a 34% increase from 2024.
- Many Indian companies want to expand abroad to gain new markets, brands, technology, and supply chain security.
- India’s domestic growth is slowing, with less foreign investment and weak private sector investment.
- Smaller Indian companies are also investing in foreign factories and acquisitions, not just large firms.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.